Entelevest’s Johnson & Johnson JNJ Stock Holding History

Entelevest’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Buy	905 +130	+17%	+$30.3K	0.2%	101
2026 Q1	$189K	Buy	+775	New	+$181K	0.19%	110

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Entelevest's JNJ Position: Q2 2026 in Review

Entelevest increased its Johnson & Johnson (JNJ) stake by 17% in Q2 2026, buying an estimated $30.3K and bringing the position to 905 shares worth $230K. The position accounts for 0.2% of the portfolio, ranked #101.

Entelevest first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Entelevest held 905 shares of Johnson & Johnson worth $230K as of Q2 2026.
Entelevest bought 130 Johnson & Johnson shares in Q2 2026, an estimated $30.3K.
Johnson & Johnson made up 0.2% of Entelevest's portfolio in Q2 2026, its #101 holding.
Entelevest first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Entelevest's 13F filing for Q2 2026, filed 22 Jul 2026.